Arthritis Research & Therapy

official impact factor 4.36

The need for prognosticators in rheumatoid arthritis. Biological and clinical markers: where are we now?

Josef S Smolen*, Daniel Aletaha, Johannes Grisar, Kurt Redlich, Günter Steiner and Oswald Wagner

Arthritis Research & Therapy 2008, 10:208 doi:10.1186/ar2418

Accesses  

  • Last 30 days: 56 accesses
  • Last year: 702 accesses
  • All time: 4665 accesses

Cited by

BioMed Central: 3 citations

Research article   Open Access

Decreases in serum levels of S100A8/9 (calprotectin) correlate with improvements in total swollen joint count in patients with recent-onset rheumatoid arthritis

Lucie Andrés Cerezo, Heřman Mann, Ondřej Pecha, Lenka Pleštilová, Karel Pavelka, Jiří Vencovský, Ladislav Šenolt Arthritis Research & Therapy 2011, 13:R122 (26 July 2011)

Research article   Open Access Highly Accessed

Blood autoantibody and cytokine profiles predict response to anti-tumor necrosis factor therapy in rheumatoid arthritis

Wolfgang Hueber, Beren H Tomooka, Franak Batliwalla, Wentian Li, Paul A Monach, Robert J Tibshirani, Ronald F Van Vollenhoven, Jon Lampa, Kazuyoshi Saito, Yoshiya Tanaka, Mark C Genovese, Lars Klareskog, Peter K Gregersen, William H Robinson Arthritis Research & Therapy 2009, 11:R76 (21 May 2009)

Review   Free Highly Accessed

Developments in the clinical understanding of rheumatoid arthritis

Josef S Smolen, Daniel Aletaha Arthritis Research & Therapy 2009, 11:204 (30 January 2009)

This article is part of a collection on The Scientific Basis of...